Hbm9161 injection (680mg and 340 mg)    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
11重症筋無力症1

11. 重症筋無力症 [臨床試験数:226,薬物数:172(DrugBank:45),標的遺伝子数:43,標的パスウェイ数:118
Searched query = "Myasthenia", "MG"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 226 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04346888
(ClinicalTrials.gov)
July 23, 202013/4/2020A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG PatientsA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Pharmacodynamic and Pharmacokinetic of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia GravisMyasthenia GravisDrug: HBM9161 Injection (680mg and 340 mg);Drug: Placebos;Drug: HBM9161 Injection (340 mg)Harbour BioMed (Guangzhou) Co. Ltd.NULLRecruiting18 Years99 YearsAll30Phase 2China